KRW 269500.0
(-1.46%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 572.86 Billion KRW | -19.88% |
2022 | 715 Billion KRW | -5.46% |
2021 | 756.26 Billion KRW | -5.72% |
2020 | 802.18 Billion KRW | -5.8% |
2019 | 851.56 Billion KRW | 34.91% |
2018 | 631.19 Billion KRW | 32.54% |
2017 | 476.24 Billion KRW | 43.35% |
2016 | 332.22 Billion KRW | -9.58% |
2015 | 367.42 Billion KRW | 34.98% |
2014 | 272.21 Billion KRW | -3.09% |
2013 | 280.89 Billion KRW | -10.36% |
2012 | 313.36 Billion KRW | 4.79% |
2011 | 299.05 Billion KRW | -1.51% |
2010 | 303.63 Billion KRW | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 518.91 Billion KRW | -8.49% |
2024 Q1 | 567.05 Billion KRW | -1.01% |
2023 Q4 | 572.86 Billion KRW | -0.55% |
2023 Q1 | 682.66 Billion KRW | -4.52% |
2023 FY | 572.86 Billion KRW | -19.88% |
2023 Q3 | 576.02 Billion KRW | -1.14% |
2023 Q2 | 582.65 Billion KRW | -14.65% |
2022 Q4 | 715 Billion KRW | 13.24% |
2022 FY | 715 Billion KRW | -5.46% |
2022 Q1 | 773.65 Billion KRW | 2.3% |
2022 Q2 | 659.73 Billion KRW | -14.73% |
2022 Q3 | 631.39 Billion KRW | -4.3% |
2021 Q2 | 785.91 Billion KRW | -5.82% |
2021 Q1 | 834.5 Billion KRW | 4.03% |
2021 Q3 | 745.92 Billion KRW | -5.09% |
2021 FY | 756.26 Billion KRW | -5.72% |
2021 Q4 | 756.26 Billion KRW | 1.39% |
2020 Q3 | 864.01 Billion KRW | -3.19% |
2020 Q2 | 892.45 Billion KRW | 0.01% |
2020 FY | 802.18 Billion KRW | -5.8% |
2020 Q1 | 892.34 Billion KRW | 4.79% |
2020 Q4 | 802.18 Billion KRW | -7.16% |
2019 Q2 | 833.12 Billion KRW | 11.81% |
2019 FY | 851.56 Billion KRW | 34.91% |
2019 Q4 | 851.56 Billion KRW | 0.71% |
2019 Q3 | 845.54 Billion KRW | 1.49% |
2019 Q1 | 745.15 Billion KRW | 18.06% |
2018 Q4 | 631.19 Billion KRW | -4.06% |
2018 Q3 | 657.87 Billion KRW | 4.62% |
2018 Q2 | 628.8 Billion KRW | 20.84% |
2018 FY | 631.19 Billion KRW | 32.54% |
2018 Q1 | 520.36 Billion KRW | 9.27% |
2017 Q4 | 476.24 Billion KRW | 7.17% |
2017 FY | 476.24 Billion KRW | 43.35% |
2017 Q2 | 373.4 Billion KRW | 14.49% |
2017 Q3 | 444.38 Billion KRW | 19.01% |
2017 Q1 | 326.15 Billion KRW | -1.83% |
2016 Q2 | 339.75 Billion KRW | -8.09% |
2016 Q4 | 332.22 Billion KRW | -2.42% |
2016 Q3 | 340.46 Billion KRW | 0.21% |
2016 FY | 332.22 Billion KRW | -9.58% |
2016 Q1 | 369.66 Billion KRW | 0.61% |
2015 Q3 | 385.89 Billion KRW | 10.93% |
2015 Q1 | 290.98 Billion KRW | 6.9% |
2015 Q2 | 347.87 Billion KRW | 19.55% |
2015 FY | 367.42 Billion KRW | 34.98% |
2015 Q4 | 367.42 Billion KRW | -4.79% |
2014 Q1 | 282.14 Billion KRW | 0.44% |
2014 FY | 272.21 Billion KRW | -3.09% |
2014 Q2 | 284.22 Billion KRW | 0.74% |
2014 Q4 | 272.21 Billion KRW | -2.52% |
2014 Q3 | 279.24 Billion KRW | -1.75% |
2013 Q4 | 280.89 Billion KRW | -2.54% |
2013 Q2 | 304.73 Billion KRW | -0.78% |
2013 FY | 280.89 Billion KRW | -10.36% |
2013 Q1 | 307.12 Billion KRW | -1.99% |
2013 Q3 | 288.22 Billion KRW | -5.42% |
2012 FY | 313.36 Billion KRW | 4.79% |
2012 Q2 | 343.7 Billion KRW | 0.18% |
2012 Q3 | 322.85 Billion KRW | -6.07% |
2012 Q4 | 313.36 Billion KRW | -2.94% |
2012 Q1 | 343.09 Billion KRW | 0.0% |
2011 Q2 | 268.75 Billion KRW | -5.48% |
2011 Q3 | 266.44 Billion KRW | -0.86% |
2011 FY | 299.05 Billion KRW | -1.51% |
2011 Q1 | 284.35 Billion KRW | 0.0% |
2010 Q3 | 272.55 Billion KRW | 0.0% |
2010 FY | 303.63 Billion KRW | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Yuyu Pharma, Inc. | 39.4 Billion KRW | -1353.714% |
Dong-A Socio Holdings Co., Ltd. | 691.88 Billion KRW | 17.202% |
Ildong Holdings Co., Ltd. | 382.06 Billion KRW | -49.942% |
HANDOK Inc. | 300.01 Billion KRW | -90.949% |
Kukje Pharma Co., Ltd. | 30.66 Billion KRW | -1768.325% |
Yuhan Corporation | 230.07 Billion KRW | -148.995% |
Dong-A ST Co., Ltd. | 406.7 Billion KRW | -40.856% |
SAMSUNG PHARM. Co., LTD. | 595.48 Million KRW | -96101.679% |
Hanall Biopharma Co.,Ltd | 1.29 Billion KRW | -44290.089% |
Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -572.697% |
Dong Sung Bio Pharm.Co.,Ltd. | 43.27 Billion KRW | -1223.85% |
MYUNGMOON Pharm co.,Ltd | 90.48 Billion KRW | -533.127% |
Hana Pharm Co., Ltd. | 26.53 Billion KRW | -2059.069% |
Yuyu Pharma, Inc. | 39.4 Billion KRW | -1353.714% |
Ilsung Pharmaceuticals Co., Ltd. | 238.12 Million KRW | -240473.181% |
REYON Pharmaceutical Co., Ltd. | 225.05 Billion KRW | -154.547% |
Aprogen pharmaceuticals,Inc. | 180.99 Billion KRW | -216.506% |
JW Holdings Corporation | 554.58 Billion KRW | -3.296% |
Ildong Pharmaceutical Co., Ltd. | 217.84 Billion KRW | -162.975% |
Chong Kun Dang Pharmaceutical Corp. | 219.76 Billion KRW | -160.674% |
JW Pharmaceutical Corporation | 170.28 Billion KRW | -236.426% |
Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -1141.277% |
Hyundai Pharmaceutical Co., Ltd. | 39.2 Billion KRW | -1361.213% |
Samil Pharmaceutical Co.,Ltd | 175.87 Billion KRW | -225.716% |
Jeil Pharmaceutical Co.,Ltd | 84.96 Billion KRW | -574.234% |
Yuyu Pharma, Inc. | 39.4 Billion KRW | -1353.714% |
Kwang Dong Pharmaceutical Co., Ltd. | 235.64 Billion KRW | -143.11% |
Daewoong pharmaceutical Co.,Ltd | 469.68 Billion KRW | -21.968% |
JW Pharmaceutical Corporation | 170.28 Billion KRW | -236.426% |
Yuhan Corporation | 230.07 Billion KRW | -148.995% |
Jeil Pharma Holdings Inc | 173.03 Billion KRW | -231.079% |
Yungjin Pharm. Co., Ltd. | 66.88 Billion KRW | -756.534% |
Suheung Co., Ltd. | 467.85 Billion KRW | -22.445% |
JW Pharmaceutical Corporation | 170.28 Billion KRW | -236.426% |
Samjin Pharmaceuticals Co., Ltd. | 118.63 Billion KRW | -382.869% |
Korea United Pharm Inc. | 40.33 Billion KRW | -1320.131% |
CKD Bio Corp. | 146.92 Billion KRW | -289.9% |
Daewon Pharmaceutical Co., Ltd. | 146.04 Billion KRW | -292.241% |
Dongwha Pharm.Co.,Ltd | 48.25 Billion KRW | -1087.158% |
Whan In Pharm Co.,Ltd. | 632.02 Million KRW | -90539.898% |
Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -1141.277% |
Chong Kun Dang Holdings Corp. | 468.03 Billion KRW | -22.399% |
Boryung Corporation | 204.21 Billion KRW | -180.521% |
Bukwang Pharmaceutical Co., Ltd. | 79.38 Billion KRW | -621.614% |
Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -572.697% |
JW Lifescience Corporation | 46.31 Billion KRW | -1136.952% |